alexa Analyzing The Effects Of Chronic Cyclooxygenase-2 Inhibition In The Gastrointestinal Tract
ISSN: 2167-0501

Biochemistry & Pharmacology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

9th World Congress on Pharmacology
September 04-06, 2017 | Paris, France

Bernadette Lazar, Mihaly Balogh, Mahmoud Al-Khrasani, Emese Bato, Eszter Ostorhazi, Terezia Laszlo, Dora Szabo, Zsuzsanna Helyes, Peter Ferdinandy, Klara Gyires and Zoltan S Zadori
Semmelweis University, Hungary
Posters & Accepted Abstracts: Biochem Pharmacol (Los Angel)
DOI: 10.4172/2167-0501-C1-007
Abstract
Introduction & Aim: It is well known that NSAIDs, which are among the most commonly used drugs worldwide, may cause gastric and duodenal ulceration, but in recent years it has been found that the distal parts of the small intestine are also injured. The patho-mechanism of this enteropathy is complex and insufficiently understood. Based on the literature, the inhibition of cyclooxygenase (COX) -1 enzyme and the acidic character of the compounds both play a role in the damage of intestinal mucosa, but it still remains controversial whether the selective inhibition of COX-2 enzyme can induce enteropathy. Thus, in our present experiment, the aim was to characterize the effects of chronic, selective COX-2 inhibition in the gastrointestinal tract. Methods: Male Wistar rats (180-200 g) were treated for 1 month with either the selective, non-acidic COX-2 inhibitor rofecoxib (5 mg/kg per day, once daily) or with its vehicle (1% methylcellulose). Gastric and intestinal mucosal injury was assessed by macroscopic and histological methods. The microbial composition of the small intestinal contents was investigated by 16S rRNA Illumina sequencing, and the effect of rofecoxib on the growth of bacteria was examined by micro dilution assay. Results: The 1-month rofecoxib treatment did not alter the body weight of the animals and did not cause significant macroscopic or histological injury in the stomach and small intestine. However, our results indicate that although rofecoxib has no direct antibacterial property, it caused significant changes in the small intestinal microbiota. Conclusion: Based on our results, selective COX-2 enzyme inhibition, even chronically, does not cause mucosal damage in the stomach or in the small intestine, but it significantly changes the gut flora composition. Our further studies will aim to reveal the cause and consequences of this dysbiosis.
Biography

Bernadette Lazar is a PhD student at Semmelweis University, where she participates in pharmacological analysis of gastrointestinal functions in rodents by using in vivo, ex vivo and in vitro methods. The aim is to characterize the COX-2 inhibitor effects at the gastrointestinal tract, and to reveal the causes and consequences of the gut flora composition change.

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords